Merck CDR Operating Income Over Time
| MRK Stock | 27.83 0.87 3.23% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Merck CDR Performance and Merck CDR Correlation. Merck |
Cross Equities Operating Income Analysis
Compare Merck CDR and related stocks such as Rubicon Organics, Applied Materials CDR, and Data Communications Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROMJ | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (5.6 M) | (12.6 M) | (9.6 M) | (12 M) | (13.3 M) | (2.6 M) | (1.1 M) | (1.2 M) | (1.3 M) | (1.4 M) |
| AMAT | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.8 B | 7.5 B | 7.9 B | 8.3 B | 9.5 B | 8.7 B |
| DCM | 8.9 M | 13.4 M | (30.1 M) | (39.1 M) | 15.6 M | (12.4 M) | 2.9 M | (2.8 M) | 12 M | 1.7 M | 24.2 M | 18.6 M | 26.7 M | 31.7 M | 37.7 M | 43.3 M | 45.5 M |
| CRM | 535 M | 535 M | 535 M | 535 M | 535 M | 535 M | 535 M | 535 M | 535 M | 463 M | 455 M | 548 M | 1.9 B | 6 B | 7.7 B | 8.8 B | 9.3 B |
| PLZ-UN | 889.1 K | 60.1 M | 40.7 M | 47 M | 55.5 M | 58.7 M | 61 M | 57.5 M | 39.6 M | 33.4 M | 35.5 M | 35.6 M | 55.1 M | 65.3 M | 65.6 M | 75.4 M | 79.2 M |
| PMZ-UN | 17.8 M | 191.9 M | 203.2 M | 152.4 M | 152.4 M | 152.4 M | 152.4 M | 152.4 M | 152.4 M | 151.2 M | 124 M | 130.9 M | 186 M | 203.5 M | 253.7 M | 351 M | 368.6 M |
| RCI-A | 403.3 M | 2.8 B | 2.8 B | 4.9 B | 5 B | 5 B | 5 B | 5.5 B | 6 B | 6.2 B | 5.8 B | 5.9 B | 6.4 B | 8.6 B | 9.6 B | 5 B | 3.3 B |
| CHE-UN | 7 M | 52.1 M | 67.2 M | 35.6 M | 19.2 M | (31.9 M) | (16.1 M) | 72.2 M | (106.1 M) | (11.3 M) | (131.1 M) | (142.7 M) | 219.2 M | 315.4 M | 243.4 M | 303.5 M | 318.7 M |
Merck CDR and related stocks such as Rubicon Organics, Applied Materials CDR, and Data Communications Operating Income description
Operating Income is the amount of profit realized from Merck CDR operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Merck CDR is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Merck CDR | MRK |
Specialization | Healthcare, Drug Manufacturers - General |
| Business Address | 126 East Lincoln |
| Exchange | Toronto Exchange |
null 27.83
Other Information on Investing in Merck Stock
Merck CDR financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck CDR security.